Skip to main content
Top
Published in: Reactions Weekly 1/2021

01-03-2021 | Tuberculosis | Case report

Adalimumab/ustekinumab

Latent tuberculosis infection: 4 case reports

Published in: Reactions Weekly | Issue 1/2021

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Daniel VT, et al. Low rate of conversion to positive tuberculosis status among patients with psoriasis on biologic therapies: A retrospective study from a US academic medical center. Journal of the American Academy of Dermatology 84: 830-833, No. 3, Mar 2021. Available from: URL: http://doi.org/10.1016/j.jaad.2020.09.075 Daniel VT, et al. Low rate of conversion to positive tuberculosis status among patients with psoriasis on biologic therapies: A retrospective study from a US academic medical center. Journal of the American Academy of Dermatology 84: 830-833, No. 3, Mar 2021. Available from: URL: http://​doi.​org/​10.​1016/​j.​jaad.​2020.​09.​075
Metadata
Title
Adalimumab/ustekinumab
Latent tuberculosis infection: 4 case reports
Publication date
01-03-2021
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-92263-9

Other articles of this Issue 1/2021

Reactions Weekly 1/2021 Go to the issue

Case report

Polaprezinc

Case report

Dobutamine

Case report

Busulfan

Case report

Minocycline

Case report

Trastuzumab